Literature DB >> 1443507

[The action of S-(+)-ketamine on serum catecholamine and cortisol. A comparison with ketamine racemate].

A Doenicke1, R Angster, M Mayer, H A Adams, G Grillenberger, A E Nebauer.   

Abstract

The S(+)-isomer of ketamine has about twice the anaesthetic potency of the commercially available racemic mixture of ketamine. It is assumed that the known side-effects of ketamine are significantly reduced when administering half the usual dose with the same pharmacodynamic effect [17, 25]. The aim of the present study was to determine the haemodynamic effects, the catecholamine and cortisol plasma levels after administration of equally potent doses of S-(+)-Ketamine and racemic mixture of ketamine. In addition, the effect of premedication with i.v. midazolam was assessed. METHOD. After approval by the ethics committee and written informed consent, 30 healthy male volunteers were randomly allocated to three groups (n = 10). Group 1 received 2 mg/kg ketamine racemate, group 2 1 mg/kg S-(+)-Ketamine, and group 3 1 mg/kg S-(+)-Ketamine 5 min after i.v.-premedication with 0.1 mg/kg midazolam. Non-invasive blood pressure (BP) and heart rate (HR) were continuously recorded. Blood samples were drawn 7 min before, and 2, 4, 8, 16, 32, 64 and 128 min after drug administration. Plasma epinephrine and norepinephrine (NE) levels were determined by HPLC and cortisol plasma levels by RIA. Data were analysed with the Kruskal-Wallis test (P < or = 0.05) for differences between groups. RESULTS. HR and BP showed a significant rise after injection of racemate and isomer, without any significant differences between groups. This was also seen for norepinephrine and cortical plasma levels. Epinephrine levels, however, differed between groups, showing a significant rise after racemate compared to isomer. Premedication with midazolam, in contrast, blunted major haemodynamic and hormonal changes. DISCUSSION. The haemodynamic changes did not differ between the racemate and isomer group despite a reduced isomer dose. HR and BP rise were similar, although epinephrine levels were significantly lower after isomer than racemate. Hence we assume that the increase in the haemodynamic parameters were mainly caused by NE. Midazolam apparently prevented the centrally mediated sympathetic stimulation caused by ketamine and its isomers. Therefore, i.v. premedication with midazolam should be applied when racemate or isomer is used, especially in high-risk cardiac patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443507

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  5 in total

Review 1.  [Role of ketamine in sepsis and systemic inflammatory response syndrome].

Authors:  M Lange; K Bröking; H van Aken; C Hucklenbruch; H-G Bone; M Westphal
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

Review 2.  Pharmacological importance of stereochemical resolution of enantiomeric drugs.

Authors:  M R Islam; J G Mahdi; I D Bowen
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.228

3.  [Sympathomimetic effects of low-dose S(+)-ketamine. Effect of propofol dosage].

Authors:  Claudia Timm; U Linstedt; T Weiss; M Zenz; C Maier
Journal:  Anaesthesist       Date:  2008-04       Impact factor: 1.041

4.  Comparison of analgesic/sedative effect of racemic ketamine and S(+)-ketamine during cardiac catheterization in newborns and children.

Authors:  C Pees; N A Haas; P Ewert; F Berger; P E Lange
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

5.  Ketamine influences the locus coeruleus norepinephrine network, with a dependency on norepinephrine transporter genotype - a placebo controlled fMRI study.

Authors:  Thomas Liebe; Meng Li; Lejla Colic; Matthias H J Munk; Catherine M Sweeney-Reed; Marie Woelfer; Moritz A Kretzschmar; Johann Steiner; Felicia von Düring; Gusalija Behnisch; Björn H Schott; Martin Walter
Journal:  Neuroimage Clin       Date:  2018-09-04       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.